How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

被引:84
作者
Kish, SJ [1 ]
机构
[1] Ctr Addict & Mental Hlth, Human Neurochem Pathol Lab, Toronto, ON M5T 1R8, Canada
关键词
ecstasy; MDMA; serotonin; brain; serotonin transporter; neurotoxicity;
D O I
10.1016/S0091-3057(01)00708-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Understanding the diverse functions of serotonin in the human brain can be obtained through examination of subjects having a lower than normal number of brain serotonin neurons. Behavioral abnormalities consistent with brain serotonergic damage have been reported in some polydrug users who also use the neurotoxin ecstasy (methylenedioxymethamphetamine, MDMA), This review evaluates the evidence from neuroimaging studies that brain serotonergic damage is a feature of human users of ecstasy. To date, neuroimaging studies designed to establish whether levels of brain serotonin neurons are lower than normal in ecstasy users have employed radioligands that bind to one component of the serotonin neuron, the serotonin transporter (SERT). Because these studies are methodologically flawed in terms of reliability or validity of the SERT measurement and appear to have employed polydrug users, no definitive information is yet available on the question of ecstasy toxicity to human brain serotonin neurons. Until these issues are resolved, it cannot be assumed that ecstasy exposure represents a chronic serotonin deficiency condition. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:845 / 855
页数:11
相关论文
共 125 条
[1]  
Aghajanian GK, 2001, NEUROPSYCHOPHARMACOL, V24, P335
[2]   α-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity [J].
Aguirre, N ;
Barrionuevo, M ;
Ramírez, MJ ;
Del Río, J ;
Lasheras, B .
NEUROREPORT, 1999, 10 (17) :3675-3680
[3]   PERSISTENT EFFECTS OF (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY) ON HUMAN SLEEP [J].
ALLEN, RP ;
MCCANN, UD ;
RICAURTE, GA .
SLEEP, 1993, 16 (06) :560-564
[4]  
[Anonymous], [No title captured]
[5]  
BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911
[6]   NEUROANATOMICAL SPECIFICITY AND TIME COURSE OF ALTERATIONS IN RAT-BRAIN SEROTONERGIC PATHWAYS INDUCED BY MDMA (3,4-METHYLENEDIOXYMETHAMPHETAMINE) - ASSESSMENT USING QUANTITATIVE AUTORADIOGRAPHY [J].
BATTAGLIA, G ;
SHARKEY, J ;
KUHAR, MJ ;
DESOUZA, EB .
SYNAPSE, 1991, 8 (04) :249-260
[7]  
Bauer L O, 1996, NIDA Res Monogr, V163, P66
[8]   NEUROPSYCHOLOGICAL DEFICITS IN ABSTINENT COCAINE ABUSERS - PRELIMINARY FINDINGS AFTER 2 WEEKS OF ABSTINENCE [J].
BERRY, J ;
VANGORP, WG ;
HERZBERG, DS ;
HINKIN, C ;
BOONE, K ;
STEINMAN, L ;
WILKINS, JN .
DRUG AND ALCOHOL DEPENDENCE, 1993, 32 (03) :231-237
[9]   Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment [J].
Bhattachary, S ;
Powell, JH .
PSYCHOLOGICAL MEDICINE, 2001, 31 (04) :647-658
[10]  
BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787